Hagenacker, Tim
3 papers on CoChatORCID 0000-0002-3631-3450
Most cited papers
- Verified
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology
Myasthenia Gravis and ThymomaPeripheral Neuropathies and Disorders
Cited by 295
- Verified
Compromised Hippocampal Neuroplasticity in the Interferon-α and Toll-like Receptor-3 Activation-Induced Mouse Depression Model
Sanchez-Mendoza, E. H., Camblor-Perujo, S., Martins Nascentes-Melo, L., Dzyubenko, E., Fleischer, M., Silva de Carvalho, T., Schmitt, L.-I., Leo, M., Hagenacker, T., Herring, A., et al. (2020) · Molecular Neurobiology
Tryptophan and brain disordersTreatment of Major Depression
Cited by 27
- Verified
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy
Stolte, B., Schreiber-Katz, O., Günther, R., Wurster, C. D., Petri, S., Osmanovic, A., Freigang, M., Uzelac, Z., Leo, M., von Velsen, O., et al. (2022) · Human Gene Therapy
Neurogenetic and Muscular Disorders ResearchVirus-based gene therapy research
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free